Evidence map›Paper›PMID 28278253›Full record

ArticlePloS one2017

Reduced bone formation markers, and altered trabecular and cortical bone mineral densities of non-paretic femurs observed in rats with ischemic stroke: A randomized controlled pilot study.

Karen N Borschmann, Sarah S Rewell, Sandra Iuliano, Ali Ghasem-Zadeh, Rachel A Davey, Heidi Ho, Peta N Skeers, Julie Bernhardt, David W Howells

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Karen N BorschmannSchool of Allied Health, La Trobe University, Bundoora, Australia.ORCID http://orcid.org/0000-0001-5364-2718
Sarah S RewellStroke Division, The Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
Sandra IulianoDepartment of Endocrinology, Austin Health, University of Melbourne, Heidelberg, Australia.
Ali Ghasem-ZadehDepartment of Endocrinology, Austin Health, University of Melbourne, Heidelberg, Australia.
Rachel A DaveyDepartment of Medicine, Austin Health, University of Melbourne, Heidelberg, Australia.
Heidi HoStroke Division, The Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
Peta N SkeersStroke Division, The Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
Julie BernhardtSchool of Allied Health, La Trobe University, Bundoora, Australia.
David W HowellsStroke Division, The Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia.
Florey Institute of Neuroscience and Mental Health · AUThe University of Melbourne · AULa Trobe University · AUUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmobility and neural damage likely contribute to accelerated bone loss after stroke, and subsequent heightened fracture risk in humans.

objectiveTo investigate the skeletal effect of middle cerebral artery occlusion (MCAo) stroke in rats and examine its utility as a model of human post-stroke bone loss.

methodsTwenty 15-week old spontaneously hypertensive male rats were randomized to MCAo or sham surgery controls. Primary outcome: group differences in trabecular bone volume fraction (BV/TV) measured by Micro-CT (10.5 micron istropic voxel size) at the ultra-distal femur of stroke affected left legs at day 28. Neurological impairments (stroke behavior and foot-faults) and physical activity (cage monitoring) were assessed at baseline, and days 1 and 27. Serum bone turnover markers (formation: N-terminal propeptide of type 1 procollagen, PINP; resorption: C-terminal telopeptide of type 1 collagen, CTX) were assessed at baseline, and days 7 and 27.

resultsNo effect of stroke was observed on BV/TV or physical activity, but PINP decreased by -24.5% (IQR -34.1, -10.5, p = 0.046) at day 27. In controls, cortical bone volume (5.2%, IQR 3.2, 6.9) and total volume (6.4%, IQR 1.2, 7.6) were higher in right legs compared to left legs, but these side-to-side differences were not evident in stroke animals.

conclusionMCAo may negatively affect bone formation. Further investigation of limb use and physical activity patterns after MCAo is required to determine the utility of this current model as a representation of human post-stroke bone loss.

Indexed as

AnimalsBiomarkersBody WeightBone DensityBone RemodelingCase-Control StudiesCollagen Type ICortical BoneDisease Models, AnimalFemurMotor ActivityPeptide FragmentsPilot ProjectsProcollagenRatsRats, Inbred SHRBiomarkersCollagen Type ICTX-I peptide, ratPeptide FragmentsProcollagenprocollagen Type I N-terminal peptide

Identifiers

PMID28278253
PMCPMC5344372
OpenAlexW2593211170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.